Abstract 16511: Time-to-controlled De-escalation Of Dual Antiplatelet Therapy Does Not Impact The Change Of Laboratory Level Of Platelet Inhibition In Primary Angioplasty

Background: Controlled de-escalation after AMI presents a real option for personalized dual antiplatelet therapy (DAPT). The randomized PRAGUE 18 study (prasugrel vs. ticagrelor in primary PCI, N 1...